Cosmos Health Files 8-K with Financials
Ticker: COSM · Form: 8-K · Filed: Sep 29, 2025 · CIK: 1474167
Sentiment: neutral
Topics: 8-K, financial-statements, regulation-fd
TL;DR
Cosmos Health dropped an 8-K with financials on 9/29/25.
AI Summary
Cosmos Health Inc. filed an 8-K on September 29, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known as Cosmos Holdings Inc. and Prime Estates & Developments Inc., is incorporated in Nevada and based in Thessaloniki, Greece.
Why It Matters
This filing provides updated financial information and disclosures for Cosmos Health Inc., which is important for investors to assess the company's current financial health and regulatory compliance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting financial statements and exhibits, with no immediate indication of significant new risks.
Key Players & Entities
- Cosmos Health Inc. (company) — Registrant
- Cosmos Holdings Inc. (company) — Former company name
- Prime Estates & Developments Inc (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- Thessaloniki, Greece (location) — Principal executive offices
- September 29, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report under Regulation FD and to include financial statements and exhibits.
When was this 8-K filed?
This 8-K was filed on September 29, 2025.
What is the exact name of the registrant?
The exact name of the registrant is Cosmos Health Inc.
In which state is Cosmos Health Inc. incorporated?
Cosmos Health Inc. is incorporated in Nevada.
What are the principal executive offices of Cosmos Health Inc.?
The principal executive offices of Cosmos Health Inc. are located at 5 Agiou Georgiou, Pilea, Thessaloniki, Greece.
Filing Stats: 811 words · 3 min read · ~3 pages · Grade level 12 · Accepted 2025-09-29 09:59:07
Filing Documents
- cosm_8k.htm (8-K) — 27KB
- cosm_ex991.htm (EX-99.1) — 52KB
- 0001477932-25-007111.txt ( ) — 210KB
- cosm-20250929.xsd (EX-101.SCH) — 5KB
- cosm-20250929_lab.xml (EX-101.LAB) — 14KB
- cosm-20250929_cal.xml (EX-101.CAL) — 1KB
- cosm-20250929_pre.xml (EX-101.PRE) — 9KB
- cosm-20250929_def.xml (EX-101.DEF) — 2KB
- cosm_8k_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On September 29, 2025, Cosmos Health Inc. (the "Company") made available its Chief Executive Officer's annual letter to shareholders for the year ended December 31, 2024, dated as of September 29, 2025. The Chief Executive Officer's annual letter contains information that may be of interest to investors. A copy of the Chief Executive Officer's annual letter is attached hereto as Exhibit 99.1 and incorporated herein by reference.
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS Certain statements contained herein constitute forward-looking statements as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These include, but are not limited to, statements relating to the Company's anticipated strategic plans and related outcomes. Forward-looking statements are not guarantees of future performance, and there can be no assurance that the Company will, or will have the ability to, execute on its anticipated strategic plans or will realize the expected outcome of its plans as anticipated or at all. They represent our intentions, plans, expectations and beliefs and are subject to numerous assumptions, risks and uncertainties. Our future results, financial condition and business may differ materially from those expressed in these forward-looking statements. You can identify many of these statements by words such as "approximates," "believes," "expects," "anticipates," "estimates," "intends," "plans," "would," "may" or other similar expressions in the Company's Annual Report on Form 10-K. For a discussion of factors that could materially affect the outcome of our forward-looking statements, see "Risk Factors" in Part I, Item 1A, of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and the other documents filed by the Company with the SEC and any amendments thereto, including the information contained in the attached letter. We do not undertake any obligation to release publicly any revisions to our forward-looking statements to reflect events or circumstances occurring after the date of this Current Report on Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being "furnished" and shall not be deemed "filed" for p
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Item Description 99.1 Chief Executive Officer's Letter, dated September 29, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COSMOS HEALTH INC. Date: September 29, 2025 By: /s/ George Terzis George Terzis Chief Financial Officer 3